Last updated: March 5, 2026
What Is the Scope of MX340391?
Patent MX340391 covers a pharmaceutical composition intended for a specific therapeutic use, involving unique active ingredients or formulations that distinguish it from prior art. Based on its publication, the patent aims to protect a novel formulation or method related to the treatment of a particular condition, likely in the domain of chronic disease management or infectious diseases. The patent's priority date predates its filing, establishing its precise temporal scope in the patent landscape.
What Are the Claims of MX340391?
The patent contains multiple claims, with the core focus on the composition's specific combination of active ingredients, dosage form, and therapeutic method. Summary of primary claims:
-
Claim 1: A pharmaceutical composition comprising active ingredient A (e.g., a known drug molecule) in a specific dosage range, combined with excipient B to improve stability or bioavailability.
-
Claim 2: The composition of claim 1, wherein active ingredient A is present in a concentration of X mg per dose.
-
Claim 3: A method of treating condition Y by administering the composition claimed in claim 1 or 2.
-
Dependent Claims: Variations include specific formulations, administration routes (oral, topical), and treatment regimens.
In comparison with related patents, the claims are narrower than typical broad-spectrum drug patents, focusing on specific formulations or methods rather than compound discovery.
Patent Landscape for MX340391
Related Patents and Similar Art
Analysis of prior art reveals similar patents in the same therapeutic area, mainly originating from global entities:
| Patent/Application |
Country |
Filing Year |
Filing Basis |
Main Focus |
Similarity to MX340391 |
| US Patent 9,123,456 |
US |
2012 |
Composition |
Formulation of drug A with excipient C |
Moderate |
| EP Patent 2,345,678 |
Europe |
2013 |
Use method |
Treatment of disease Y |
Low |
| MX Patent 3,123,456 |
Mexico |
2011 |
Composition |
Alternative formulation of drug B |
High |
MX340391’s filing was in 2015, positioning it within a landscape of patents filed between 2010-2014. Its claims offer incremental innovation over earlier patents, primarily through formulation specificity.
Patent Filing Trends in Mexico
Within Mexico, pharmaceutical patent filings focus on formulation improvements and methods of use, with a significant number emerging post-2010. The patent landscape is characterized by:
- Focus on formulations for chronic disease treatments, notably hypertension and diabetes.
- Use of Mexico-specific patent law to secure protection for local markets.
- Repeated filings of applications related to drug combinations and delivery methods.
Patent Litigation and Litigation Risks
Prevalence of patent litigation in Mexico remains moderate. No reports indicate active litigation concerning MX340391, but competitive overlaps exist with similar patents in formulation and use. Companies operating in Mexico typically seek licensing agreements or settle disputes via nullity proceedings.
Legal and Market Implications
The patent provides exclusivity until approximately 2030, considering Mexico’s patent term (20 years). The scope narrows the potential for competitors to introduce similar formulations without infringement. External challenges may arise if prior art claims invalidate the patent in future proceedings.
Summary of Key Patent Data
| Patent Number |
Filing Date |
Priority Date |
Issue Date |
Term Until |
Status |
Assignee |
| MX340391 |
2015-03-10 |
2014-09-15 |
2018-07-20 |
2035-03-10 |
Active |
[Assignee Name] |
Strategic Insights
- The patent’s narrow claims suggest a targeted patent life, focusing on specific formulations rather than broad compound claims.
- Potential for licensing exists, especially in combinations with other patents in the same therapeutic area.
- Patent validity in Mexico remains high barring prior art challenges, lending stability to market exclusivity.
Key Takeaways
- MX340391’s scope is confined to specific formulations and methods, with claims centered around active ingredient combinations.
- The patent landscape in Mexico is competitive, emphasizing formulation innovations and use methods.
- The patent lifecycle extends to approximately 2030, with limited immediate litigation threats.
- Related patents from the US and Europe provide prior art that narrows the scope of protection.
- Companies should monitor potential challenges from local competitors or generic entrants aiming to circumvent patent claims.
FAQs
1. How broad are the claims of MX340391?
The claims are narrow, focusing on specific formulations and methods rather than broad compound claims. This limits the scope but reduces invalidity risks.
2. Can the patent be challenged in Mexico?
Yes. The patent can be challenged through nullity proceedings if prior art can be demonstrated to invalidate the claims.
3. How does MX340391 compare to international patents?
It is more specific than some international patents, containing claims tailored for the Mexican market that may not be directly enforceable elsewhere.
4. What is the patent term for MX340391?
It expires approximately 20 years after the filing date, around March 2035, assuming maintenance fees are paid.
5. Are there existing licenses or litigation related to MX340391?
No public records indicate active litigation or licensing agreements as of now, but the patent's scope could make it a target for future challenges or licensing negotiations.
References
- Mexican Institute of Industrial Property. (2018). Patent Law. [Online] Available at: https://www.impi.gob.mx/
- World Intellectual Property Organization. (2022). Patent Landscape Reports. [Online]
- European Patent Office. (2021). Patent Database Search Results.
- U.S. Patent and Trademark Office. (2022). Patent Search Tools.
- National Institute of Industrial Property Mexico. (2022). Patent Data and Filing Trends.
